The Future of Cannabis Legalization in Europe: What It Means for the UK
The entire cannabis landscape is changing very rapidly across Europe. Germany is pushing ahead with full legalization, the Czech Republic is moving toward a more liberal regulatory framework, and Spain is expanding its medical framework. The dominoes are falling, one by one. The UK? Still having parliamentary discussion while underground sessions all over the UK are booming.
What to Expect
Medical expansion
Medical cannabis access is increasing across Europe. Germany, Italy, and Poland have already provided access to prescriptive medications covered by insurance. If the UK were to expand medical qualifications, including eliminating the cost of imports, many chronic pain and epilepsy patients could possibly have alternatives to opioids, as well as safer medications.
Pilot projects
Look for “cannabis tolerance zones” in progressive cities in Europe. These are possible localized decriminalization projects to allow authorities to experiment with the public health and law enforcement implications of legal cannabis use. For the UK, these types of pilots could help overcome political deadlock and provide actual empirical data with respect to public health and police efforts.
The economic impact
Germany estimates several billion dollars annually in cannabis taxation, competing with the craft alcohol and tobacco sectors. Licensed cultivation and retail establishments and auxiliary services drive thousands of jobs. If the UK moves late into the market, the country not only lets the revenue slip away but also the opportunity to influence the European cannabis market. Perils of Inaction
Risking Falling
- Behind Our Neighbors: While other nations are seeing their legal markets and experimentation take place, the UK could find itself working with old outdated laws.
- Loss of Opportunity: Capital follows certainty in the laws. Right now, the only markets where there is stable law is Germany, the Netherlands, and Portugal.
- Growing Black Market: Prohibition does not erase demand. Prohibition grows underground systems that do not protect consumers from unsafe, untested products.
The Voice of the Activist
“If the UK doesn’t kick into high gear by 2026, we will have to import not just cannabis but the whole industry and jobs.”
That’s the warning from a leading campaigner. And, it’s not just alarmism. Germany will soon be celebrating its 1st year of legal retail sales, and already measuring high volume: Billions in tax revenue, reduce street dealing, thriving ecosystem of licensed growers and shop owners active in supplying a legal market.
Country and State Patients, are traveling to Amsterdam, Barcelona and Berlin to gain access to treatment that is technically illegal in the UK. Country and State entrepreneurs are applying for businesses in other countries to appear legitimate while the capital investment ship has sailed right past London directly into Berlin and Prague.
The UK still has a trump card.
Contrarily, it’s not all bad. The UK actually has a high valued card to play, which has long-standing history with leading the world on medical research. The UK laboratory has decades of cannabinoid research history behind it and its pharmaceutical production is second to none in the world, so if the reform advocates can nudge the state toward logical, reason-based legalization when it comes for cannabis – the UK could be the epicenter of innovation in the medical cannabis field; not simply a consumer market.
The Next Big Decision
The next years will determine whether the UK leads on cannabis reform or simply watches. Europe is moving forward, with the rationale, data, and economic impact of legalization are irrefutable. What is a question is whether Westminster will watch the opportunity go by — or wants to take the opportunity to lead.
Discover more cannabis news and information in our blog.